125 related articles for article (PubMed ID: 20060545)
1. Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke.
Nishiyama Y; Ueda M; Katsura K; Otsuka T; Abe A; Nagayama H; Katayama Y
J Neurol Sci; 2010 Mar; 290(1-2):12-5. PubMed ID: 20060545
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric dimethylarginine as a risk marker for early-onset ischemic stroke in Indian population.
Mamatha SN; Nagaraja D; Philip M; Christopher R
Clin Chim Acta; 2011 Jan; 412(1-2):139-42. PubMed ID: 20883678
[TBL] [Abstract][Full Text] [Related]
3. Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke.
Ercan M; Mungan S; Güzel I; Celik HT; Bal C; Abusoglu S; Akbulut D; Oguz EF; Yilmaz FM
Adv Clin Exp Med; 2019 May; 28(5):693-698. PubMed ID: 30170483
[TBL] [Abstract][Full Text] [Related]
4. Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in ischemic stroke patients.
Nishiyama Y; Ueda M; Otsuka T; Katsura K; Abe A; Nagayama H; Katayama Y
J Atheroscler Thromb; 2011; 18(2):131-7. PubMed ID: 21081834
[TBL] [Abstract][Full Text] [Related]
5. The L-arginine pathway in acute ischemic stroke and severe carotid stenosis: temporal profiles and association with biomarkers and outcome.
Molnar T; Pusch G; Papp V; Feher G; Szapary L; Biri B; Nagy L; Keki S; Illes Z
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2206-2214. PubMed ID: 25018114
[TBL] [Abstract][Full Text] [Related]
6. Supplementation of folic acid and vitamin B₁₂ reduces plasma levels of asymmetric dimethylarginine in patients with acute ischemic stroke.
Xia XS; Li X; Wang L; Wang JZ; Ma JP; Wu CJ
J Clin Neurosci; 2014 Sep; 21(9):1586-90. PubMed ID: 24814858
[TBL] [Abstract][Full Text] [Related]
7. Comparison of plasma viscosity as a marker of endothelial dysfunction with nitric oxide and asymmetric dimethylarginine in subjects with dyslipidemia.
Ercan M; Firtina S; Konukoglu D
Clin Hemorheol Microcirc; 2014; 57(4):315-23. PubMed ID: 23455843
[TBL] [Abstract][Full Text] [Related]
8. The value of serum asymmetric dimethylarginine levels for the determination of masked hypertension in patients with diabetes mellitus.
Taner A; Unlu A; Kayrak M; Tekinalp M; Ayhan SS; Arıbaş A; Erdem SS
Atherosclerosis; 2013 Jun; 228(2):432-7. PubMed ID: 23540293
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric dimethylarginine is related to the predicted stroke risk in middle-aged Japanese men.
Nishiyama Y; Otsuka T; Ueda M; Inagaki H; Muraga K; Abe A; Kawada T; Katayama Y
J Neurol Sci; 2014 Mar; 338(1-2):87-91. PubMed ID: 24380688
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1(sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma.
Vasilev V; Matrozova J; Elenkova A; Vandeva S; Kirilov G; Zacharieva S
Exp Clin Endocrinol Diabetes; 2013 Oct; 121(9):551-5. PubMed ID: 24002898
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Suzuki T; Ueda Y; Yamada S; Shoji H; Takeuchi M; Ueda S; Matsui T; Adachi H; Okuda S; Yamagishi S
Pharmacol Res; 2009 Dec; 60(6):515-8. PubMed ID: 19450686
[TBL] [Abstract][Full Text] [Related]
12. Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Ueda Y; Suzuki T; Ueda S; Adachi H; Okuda S; Yamagishi S
Pharmacol Res; 2009 Dec; 60(6):525-8. PubMed ID: 19409491
[TBL] [Abstract][Full Text] [Related]
13. Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations.
Altinova AE; Arslan M; Sepici-Dincel A; Akturk M; Altan N; Toruner FB
J Clin Endocrinol Metab; 2007 May; 92(5):1881-5. PubMed ID: 17311854
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
Maas R; Dentz L; Schwedhelm E; Thoms W; Kuss O; Hiltmeyer N; Haddad M; Klöss T; Standl T; Böger RH
Crit Care Med; 2007 Aug; 35(8):1876-81. PubMed ID: 17581491
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population.
Wanby P; Teerlink T; Brudin L; Brattström L; Nilsson I; Palmqvist P; Carlsson M
Atherosclerosis; 2006 Apr; 185(2):271-7. PubMed ID: 16055131
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg.
Leong T; Zylberstein D; Graham I; Lissner L; Ward D; Fogarty J; Bengtsson C; Björkelund C; Thelle D;
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):961-7. PubMed ID: 18292394
[TBL] [Abstract][Full Text] [Related]
18. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
Ozcan O; Cakir E; Yaman H; Akgul EO; Erturk K; Beyhan Z; Bilgi C; Erbil MK
Clin Endocrinol (Oxf); 2005 Aug; 63(2):203-6. PubMed ID: 16060915
[TBL] [Abstract][Full Text] [Related]
19. [ADMA (asymmetric dimethylarginine)--the inhibitor of nitric oxide (NO) synthesis: a new marker for vascular pathology].
Sela BA
Harefuah; 2005 Sep; 144(9):655-9, 675, 674. PubMed ID: 16218539
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats.
Zheng D; Liang Q; Zeng F; Mai Z; Cai A; Qiu R; Xu R; Li D; Mai W
Lipids Health Dis; 2015 May; 14():41. PubMed ID: 25934565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
